secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kymera Therapeutics, Inc. (KYMR)
CIK:        0001815442
Form:       8-K
Filed at:   2023-02-27T23:59:59+00:00
Accession:  0001193125-23-051009
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Kymera Therapeutics CBO Elaine Caughey to depart April 10, 2023
---------------------------------------------------------------

- Chief Business Officer Elaine Caughey departing for personal family reasons.
- Departure effective as of April 10, 2023.
- No replacement or interim appointment announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815442/000119312523051009/0001193125-23-051009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815442/000119312523051009/d463391d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-051009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer